HEADER TRANSFERASE 12-MAR-18 6FYK TITLE X-RAY STRUCTURE OF CLK2-KD(136-496)/INDAZOLE1 AT 2.39A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CDC-LIKE KINASE 2; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SPLICING, PHOSPHOTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 5 17-JAN-24 6FYK 1 REMARK REVDAT 4 03-OCT-18 6FYK 1 REMARK REVDAT 3 26-SEP-18 6FYK 1 JRNL REVDAT 2 12-SEP-18 6FYK 1 JRNL REVDAT 1 18-JUL-18 6FYK 0 JRNL AUTH J.KALLEN,C.BERGSDORF,B.ARNAUD,M.BERNHARD,M.BRICHET, JRNL AUTH 2 A.COBOS-CORREA,A.ELHAJOUJI,F.FREULER,I.GALIMBERTI, JRNL AUTH 3 C.GUIBOURDENCHE,S.HAENNI,S.HOLZINGER,J.HUNZIKER,A.IZAAC, JRNL AUTH 4 M.KAUFMANN,L.LEDER,H.J.MARTUS,P.VON MATT,V.POLYAKOV, JRNL AUTH 5 P.ROETHLISBERGER,G.ROMA,N.STIEFL,M.UTENG,A.LERCHNER JRNL TITL X-RAY STRUCTURES AND FEASIBILITY ASSESSMENT OF CLK2 JRNL TITL 2 INHIBITORS FOR PHELAN-MCDERMID SYNDROME. JRNL REF CHEMMEDCHEM V. 13 1997 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29985556 JRNL DOI 10.1002/CMDC.201800344 REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 45140 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2376 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8709 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 466 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.04000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.13000 REMARK 3 B12 (A**2) : 0.04000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.514 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.252 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.171 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.441 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6FYK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009135. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99986 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47518 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 19.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : 0.16300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.50 REMARK 200 R MERGE FOR SHELL (I) : 0.92700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6FYI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG2000, 0.2M TRIMETHYLAMINE N REMARK 280 -OXIDE, 0.1M TRIS, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 148.57200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.28600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 74.28600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 148.57200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 701 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 134 REMARK 465 PRO A 135 REMARK 465 SER A 136 REMARK 465 PRO A 486 REMARK 465 PRO A 487 REMARK 465 ASN A 488 REMARK 465 LYS A 489 REMARK 465 LEU A 490 REMARK 465 TRP A 491 REMARK 465 ASP A 492 REMARK 465 SER A 493 REMARK 465 SER A 494 REMARK 465 ARG A 495 REMARK 465 ASP A 496 REMARK 465 GLY B 134 REMARK 465 PRO B 135 REMARK 465 SER B 136 REMARK 465 PRO B 486 REMARK 465 PRO B 487 REMARK 465 ASN B 488 REMARK 465 LYS B 489 REMARK 465 LEU B 490 REMARK 465 TRP B 491 REMARK 465 ASP B 492 REMARK 465 SER B 493 REMARK 465 SER B 494 REMARK 465 ARG B 495 REMARK 465 ASP B 496 REMARK 465 GLY C 134 REMARK 465 PRO C 135 REMARK 465 SER C 136 REMARK 465 PRO C 486 REMARK 465 PRO C 487 REMARK 465 ASN C 488 REMARK 465 LYS C 489 REMARK 465 LEU C 490 REMARK 465 TRP C 491 REMARK 465 ASP C 492 REMARK 465 SER C 493 REMARK 465 SER C 494 REMARK 465 ARG C 495 REMARK 465 ASP C 496 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 162 -54.51 -138.52 REMARK 500 ARG A 185 43.21 -149.95 REMARK 500 ASN A 197 47.55 -80.48 REMARK 500 THR A 289 -17.13 77.07 REMARK 500 ASP A 327 94.51 62.38 REMARK 500 SER A 343 144.52 71.50 REMARK 500 SER A 359 -141.96 -145.16 REMARK 500 ARG A 481 19.22 -60.43 REMARK 500 ARG B 162 -51.19 -147.38 REMARK 500 ASN B 197 47.95 -76.95 REMARK 500 THR B 289 -15.28 73.72 REMARK 500 ASP B 327 89.02 65.04 REMARK 500 SER B 343 147.64 72.32 REMARK 500 SER B 359 -146.72 -149.58 REMARK 500 ARG B 483 -166.45 -71.65 REMARK 500 ARG C 162 -53.36 -151.97 REMARK 500 ARG C 185 54.14 -107.05 REMARK 500 ASN C 222 73.73 59.88 REMARK 500 PHE C 230 -62.10 -94.70 REMARK 500 THR C 289 -20.32 73.58 REMARK 500 ASP C 327 94.13 66.62 REMARK 500 SER C 343 147.90 73.44 REMARK 500 ARG C 345 -58.43 -29.96 REMARK 500 SER C 359 -146.98 -153.19 REMARK 500 ARG C 483 -161.01 -63.51 REMARK 500 ALA C 484 92.05 -50.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAZ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAZ B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAZ C 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FYI RELATED DB: PDB DBREF 6FYK A 136 496 UNP P49760 CLK2_HUMAN 136 496 DBREF 6FYK B 136 496 UNP P49760 CLK2_HUMAN 136 496 DBREF 6FYK C 136 496 UNP P49760 CLK2_HUMAN 136 496 SEQADV 6FYK GLY A 134 UNP P49760 EXPRESSION TAG SEQADV 6FYK PRO A 135 UNP P49760 EXPRESSION TAG SEQADV 6FYK GLY B 134 UNP P49760 EXPRESSION TAG SEQADV 6FYK PRO B 135 UNP P49760 EXPRESSION TAG SEQADV 6FYK GLY C 134 UNP P49760 EXPRESSION TAG SEQADV 6FYK PRO C 135 UNP P49760 EXPRESSION TAG SEQRES 1 A 363 GLY PRO SER SER ARG ARG ALA LYS SER VAL GLU ASP ASP SEQRES 2 A 363 ALA GLU GLY HIS LEU ILE TYR HIS VAL GLY ASP TRP LEU SEQRES 3 A 363 GLN GLU ARG TYR GLU ILE VAL SER THR LEU GLY GLU GLY SEQRES 4 A 363 THR PHE GLY ARG VAL VAL GLN CYS VAL ASP HIS ARG ARG SEQRES 5 A 363 GLY GLY ALA ARG VAL ALA LEU LYS ILE ILE LYS ASN VAL SEQRES 6 A 363 GLU LYS TYR LYS GLU ALA ALA ARG LEU GLU ILE ASN VAL SEQRES 7 A 363 LEU GLU LYS ILE ASN GLU LYS ASP PRO ASP ASN LYS ASN SEQRES 8 A 363 LEU CYS VAL GLN MET PHE ASP TRP PHE ASP TYR HIS GLY SEQRES 9 A 363 HIS MET CYS ILE SER PHE GLU LEU LEU GLY LEU SER THR SEQRES 10 A 363 PHE ASP PHE LEU LYS ASP ASN ASN TYR LEU PRO TYR PRO SEQRES 11 A 363 ILE HIS GLN VAL ARG HIS MET ALA PHE GLN LEU CYS GLN SEQRES 12 A 363 ALA VAL LYS PHE LEU HIS ASP ASN LYS LEU THR HIS THR SEQRES 13 A 363 ASP LEU LYS PRO GLU ASN ILE LEU PHE VAL ASN SER ASP SEQRES 14 A 363 TYR GLU LEU THR TYR ASN LEU GLU LYS LYS ARG ASP GLU SEQRES 15 A 363 ARG SER VAL LYS SER THR ALA VAL ARG VAL VAL ASP PHE SEQRES 16 A 363 GLY SER ALA THR PHE ASP HIS GLU HIS HIS SER THR ILE SEQRES 17 A 363 VAL SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU SEQRES 18 A 363 GLU LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE SEQRES 19 A 363 GLY CYS ILE ILE PHE GLU TYR TYR VAL GLY PHE THR LEU SEQRES 20 A 363 PHE GLN THR HIS ASP ASN ARG GLU HIS LEU ALA MET MET SEQRES 21 A 363 GLU ARG ILE LEU GLY PRO ILE PRO SER ARG MET ILE ARG SEQRES 22 A 363 LYS THR ARG LYS GLN LYS TYR PHE TYR ARG GLY ARG LEU SEQRES 23 A 363 ASP TRP ASP GLU ASN THR SER ALA GLY ARG TYR VAL ARG SEQRES 24 A 363 GLU ASN CYS LYS PRO LEU ARG ARG TYR LEU THR SER GLU SEQRES 25 A 363 ALA GLU GLU HIS HIS GLN LEU PHE ASP LEU ILE GLU SER SEQRES 26 A 363 MET LEU GLU TYR GLU PRO ALA LYS ARG LEU THR LEU GLY SEQRES 27 A 363 GLU ALA LEU GLN HIS PRO PHE PHE ALA ARG LEU ARG ALA SEQRES 28 A 363 GLU PRO PRO ASN LYS LEU TRP ASP SER SER ARG ASP SEQRES 1 B 363 GLY PRO SER SER ARG ARG ALA LYS SER VAL GLU ASP ASP SEQRES 2 B 363 ALA GLU GLY HIS LEU ILE TYR HIS VAL GLY ASP TRP LEU SEQRES 3 B 363 GLN GLU ARG TYR GLU ILE VAL SER THR LEU GLY GLU GLY SEQRES 4 B 363 THR PHE GLY ARG VAL VAL GLN CYS VAL ASP HIS ARG ARG SEQRES 5 B 363 GLY GLY ALA ARG VAL ALA LEU LYS ILE ILE LYS ASN VAL SEQRES 6 B 363 GLU LYS TYR LYS GLU ALA ALA ARG LEU GLU ILE ASN VAL SEQRES 7 B 363 LEU GLU LYS ILE ASN GLU LYS ASP PRO ASP ASN LYS ASN SEQRES 8 B 363 LEU CYS VAL GLN MET PHE ASP TRP PHE ASP TYR HIS GLY SEQRES 9 B 363 HIS MET CYS ILE SER PHE GLU LEU LEU GLY LEU SER THR SEQRES 10 B 363 PHE ASP PHE LEU LYS ASP ASN ASN TYR LEU PRO TYR PRO SEQRES 11 B 363 ILE HIS GLN VAL ARG HIS MET ALA PHE GLN LEU CYS GLN SEQRES 12 B 363 ALA VAL LYS PHE LEU HIS ASP ASN LYS LEU THR HIS THR SEQRES 13 B 363 ASP LEU LYS PRO GLU ASN ILE LEU PHE VAL ASN SER ASP SEQRES 14 B 363 TYR GLU LEU THR TYR ASN LEU GLU LYS LYS ARG ASP GLU SEQRES 15 B 363 ARG SER VAL LYS SER THR ALA VAL ARG VAL VAL ASP PHE SEQRES 16 B 363 GLY SER ALA THR PHE ASP HIS GLU HIS HIS SER THR ILE SEQRES 17 B 363 VAL SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU SEQRES 18 B 363 GLU LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE SEQRES 19 B 363 GLY CYS ILE ILE PHE GLU TYR TYR VAL GLY PHE THR LEU SEQRES 20 B 363 PHE GLN THR HIS ASP ASN ARG GLU HIS LEU ALA MET MET SEQRES 21 B 363 GLU ARG ILE LEU GLY PRO ILE PRO SER ARG MET ILE ARG SEQRES 22 B 363 LYS THR ARG LYS GLN LYS TYR PHE TYR ARG GLY ARG LEU SEQRES 23 B 363 ASP TRP ASP GLU ASN THR SER ALA GLY ARG TYR VAL ARG SEQRES 24 B 363 GLU ASN CYS LYS PRO LEU ARG ARG TYR LEU THR SER GLU SEQRES 25 B 363 ALA GLU GLU HIS HIS GLN LEU PHE ASP LEU ILE GLU SER SEQRES 26 B 363 MET LEU GLU TYR GLU PRO ALA LYS ARG LEU THR LEU GLY SEQRES 27 B 363 GLU ALA LEU GLN HIS PRO PHE PHE ALA ARG LEU ARG ALA SEQRES 28 B 363 GLU PRO PRO ASN LYS LEU TRP ASP SER SER ARG ASP SEQRES 1 C 363 GLY PRO SER SER ARG ARG ALA LYS SER VAL GLU ASP ASP SEQRES 2 C 363 ALA GLU GLY HIS LEU ILE TYR HIS VAL GLY ASP TRP LEU SEQRES 3 C 363 GLN GLU ARG TYR GLU ILE VAL SER THR LEU GLY GLU GLY SEQRES 4 C 363 THR PHE GLY ARG VAL VAL GLN CYS VAL ASP HIS ARG ARG SEQRES 5 C 363 GLY GLY ALA ARG VAL ALA LEU LYS ILE ILE LYS ASN VAL SEQRES 6 C 363 GLU LYS TYR LYS GLU ALA ALA ARG LEU GLU ILE ASN VAL SEQRES 7 C 363 LEU GLU LYS ILE ASN GLU LYS ASP PRO ASP ASN LYS ASN SEQRES 8 C 363 LEU CYS VAL GLN MET PHE ASP TRP PHE ASP TYR HIS GLY SEQRES 9 C 363 HIS MET CYS ILE SER PHE GLU LEU LEU GLY LEU SER THR SEQRES 10 C 363 PHE ASP PHE LEU LYS ASP ASN ASN TYR LEU PRO TYR PRO SEQRES 11 C 363 ILE HIS GLN VAL ARG HIS MET ALA PHE GLN LEU CYS GLN SEQRES 12 C 363 ALA VAL LYS PHE LEU HIS ASP ASN LYS LEU THR HIS THR SEQRES 13 C 363 ASP LEU LYS PRO GLU ASN ILE LEU PHE VAL ASN SER ASP SEQRES 14 C 363 TYR GLU LEU THR TYR ASN LEU GLU LYS LYS ARG ASP GLU SEQRES 15 C 363 ARG SER VAL LYS SER THR ALA VAL ARG VAL VAL ASP PHE SEQRES 16 C 363 GLY SER ALA THR PHE ASP HIS GLU HIS HIS SER THR ILE SEQRES 17 C 363 VAL SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU SEQRES 18 C 363 GLU LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE SEQRES 19 C 363 GLY CYS ILE ILE PHE GLU TYR TYR VAL GLY PHE THR LEU SEQRES 20 C 363 PHE GLN THR HIS ASP ASN ARG GLU HIS LEU ALA MET MET SEQRES 21 C 363 GLU ARG ILE LEU GLY PRO ILE PRO SER ARG MET ILE ARG SEQRES 22 C 363 LYS THR ARG LYS GLN LYS TYR PHE TYR ARG GLY ARG LEU SEQRES 23 C 363 ASP TRP ASP GLU ASN THR SER ALA GLY ARG TYR VAL ARG SEQRES 24 C 363 GLU ASN CYS LYS PRO LEU ARG ARG TYR LEU THR SER GLU SEQRES 25 C 363 ALA GLU GLU HIS HIS GLN LEU PHE ASP LEU ILE GLU SER SEQRES 26 C 363 MET LEU GLU TYR GLU PRO ALA LYS ARG LEU THR LEU GLY SEQRES 27 C 363 GLU ALA LEU GLN HIS PRO PHE PHE ALA ARG LEU ARG ALA SEQRES 28 C 363 GLU PRO PRO ASN LYS LEU TRP ASP SER SER ARG ASP HET EAZ A 501 24 HET EAZ B 501 24 HET EAZ C 501 24 HETNAM EAZ (2~{S})-4-METHYL-1-[5-(3-METHYL-2~{H}-INDAZOL-5-YL) HETNAM 2 EAZ PYRIDIN-3-YL]OXY-PENTAN-2-AMINE FORMUL 4 EAZ 3(C19 H24 N4 O) FORMUL 7 HOH *466(H2 O) HELIX 1 AA1 VAL A 198 ASP A 219 1 22 HELIX 2 AA2 SER A 249 ASN A 257 1 9 HELIX 3 AA3 PRO A 263 ASN A 284 1 22 HELIX 4 AA4 LYS A 292 GLU A 294 5 3 HELIX 5 AA5 THR A 344 ARG A 348 5 5 HELIX 6 AA6 ALA A 349 LEU A 354 1 6 HELIX 7 AA7 GLN A 360 GLY A 377 1 18 HELIX 8 AA8 ASP A 385 GLY A 398 1 14 HELIX 9 AA9 PRO A 401 THR A 408 1 8 HELIX 10 AB1 LYS A 410 LYS A 412 5 3 HELIX 11 AB2 THR A 425 CYS A 435 1 11 HELIX 12 AB3 PRO A 437 LEU A 442 5 6 HELIX 13 AB4 ALA A 446 LEU A 460 1 15 HELIX 14 AB5 GLU A 463 ARG A 467 5 5 HELIX 15 AB6 THR A 469 LEU A 474 1 6 HELIX 16 AB7 GLN A 475 LEU A 482 5 8 HELIX 17 AB8 VAL B 198 ASP B 219 1 22 HELIX 18 AB9 SER B 249 ASN B 257 1 9 HELIX 19 AC1 PRO B 263 ASP B 283 1 21 HELIX 20 AC2 LYS B 292 GLU B 294 5 3 HELIX 21 AC3 THR B 344 ARG B 348 5 5 HELIX 22 AC4 ALA B 349 LEU B 354 1 6 HELIX 23 AC5 GLN B 360 GLY B 377 1 18 HELIX 24 AC6 ASP B 385 GLY B 398 1 14 HELIX 25 AC7 PRO B 401 THR B 408 1 8 HELIX 26 AC8 LYS B 410 LYS B 412 5 3 HELIX 27 AC9 THR B 425 CYS B 435 1 11 HELIX 28 AD1 PRO B 437 LEU B 442 5 6 HELIX 29 AD2 ALA B 446 LEU B 460 1 15 HELIX 30 AD3 GLU B 463 ARG B 467 5 5 HELIX 31 AD4 THR B 469 LEU B 474 1 6 HELIX 32 AD5 GLN B 475 ALA B 480 5 6 HELIX 33 AD6 VAL C 198 ASP C 219 1 22 HELIX 34 AD7 SER C 249 ASN C 257 1 9 HELIX 35 AD8 PRO C 263 ASP C 283 1 21 HELIX 36 AD9 LYS C 292 GLU C 294 5 3 HELIX 37 AE1 THR C 344 ARG C 348 5 5 HELIX 38 AE2 ALA C 349 LEU C 354 1 6 HELIX 39 AE3 GLN C 360 GLY C 377 1 18 HELIX 40 AE4 ASP C 385 GLY C 398 1 14 HELIX 41 AE5 PRO C 401 THR C 408 1 8 HELIX 42 AE6 LYS C 410 LYS C 412 5 3 HELIX 43 AE7 THR C 425 CYS C 435 1 11 HELIX 44 AE8 PRO C 437 LEU C 442 5 6 HELIX 45 AE9 ALA C 446 LEU C 460 1 15 HELIX 46 AF1 THR C 469 GLN C 475 1 7 HELIX 47 AF2 HIS C 476 ALA C 480 5 5 SHEET 1 AA1 6 TRP A 158 LEU A 159 0 SHEET 2 AA1 6 TYR A 163 GLY A 172 -1 O TYR A 163 N LEU A 159 SHEET 3 AA1 6 GLY A 175 ASP A 182 -1 O GLN A 179 N VAL A 166 SHEET 4 AA1 6 ARG A 189 ILE A 195 -1 O LEU A 192 N VAL A 178 SHEET 5 AA1 6 HIS A 238 GLU A 244 -1 O MET A 239 N ILE A 195 SHEET 6 AA1 6 MET A 229 TYR A 235 -1 N ASP A 231 O SER A 242 SHEET 1 AA2 2 LEU A 286 THR A 287 0 SHEET 2 AA2 2 THR A 332 PHE A 333 -1 O THR A 332 N THR A 287 SHEET 1 AA3 2 ILE A 296 PHE A 298 0 SHEET 2 AA3 2 VAL A 323 VAL A 325 -1 O ARG A 324 N LEU A 297 SHEET 1 AA4 2 TYR A 303 ASN A 308 0 SHEET 2 AA4 2 ARG A 313 VAL A 318 -1 O SER A 317 N GLU A 304 SHEET 1 AA5 2 PHE A 414 TYR A 415 0 SHEET 2 AA5 2 ARG A 418 LEU A 419 -1 O ARG A 418 N TYR A 415 SHEET 1 AA6 6 TRP B 158 LEU B 159 0 SHEET 2 AA6 6 TYR B 163 GLU B 171 -1 O TYR B 163 N LEU B 159 SHEET 3 AA6 6 GLY B 175 ASP B 182 -1 O GLN B 179 N VAL B 166 SHEET 4 AA6 6 ARG B 189 ILE B 195 -1 O LEU B 192 N VAL B 178 SHEET 5 AA6 6 HIS B 238 GLU B 244 -1 O ILE B 241 N LYS B 193 SHEET 6 AA6 6 MET B 229 TYR B 235 -1 N PHE B 233 O CYS B 240 SHEET 1 AA7 2 LEU B 286 THR B 287 0 SHEET 2 AA7 2 THR B 332 PHE B 333 -1 O THR B 332 N THR B 287 SHEET 1 AA8 2 ILE B 296 PHE B 298 0 SHEET 2 AA8 2 VAL B 323 VAL B 325 -1 O ARG B 324 N LEU B 297 SHEET 1 AA9 2 TYR B 303 ASN B 308 0 SHEET 2 AA9 2 ARG B 313 VAL B 318 -1 O SER B 317 N GLU B 304 SHEET 1 AB1 2 PHE B 414 TYR B 415 0 SHEET 2 AB1 2 ARG B 418 LEU B 419 -1 O ARG B 418 N TYR B 415 SHEET 1 AB2 6 TRP C 158 LEU C 159 0 SHEET 2 AB2 6 TYR C 163 GLU C 171 -1 O TYR C 163 N LEU C 159 SHEET 3 AB2 6 GLY C 175 ASP C 182 -1 O GLN C 179 N SER C 167 SHEET 4 AB2 6 ARG C 189 ILE C 195 -1 O ILE C 194 N ARG C 176 SHEET 5 AB2 6 HIS C 238 GLU C 244 -1 O MET C 239 N ILE C 195 SHEET 6 AB2 6 MET C 229 TYR C 235 -1 N ASP C 231 O SER C 242 SHEET 1 AB3 2 LEU C 286 THR C 287 0 SHEET 2 AB3 2 THR C 332 PHE C 333 -1 O THR C 332 N THR C 287 SHEET 1 AB4 2 ILE C 296 PHE C 298 0 SHEET 2 AB4 2 VAL C 323 VAL C 325 -1 O ARG C 324 N LEU C 297 SHEET 1 AB5 2 TYR C 303 ASN C 308 0 SHEET 2 AB5 2 ARG C 313 VAL C 318 -1 O GLU C 315 N THR C 306 SHEET 1 AB6 2 PHE C 414 TYR C 415 0 SHEET 2 AB6 2 ARG C 418 LEU C 419 -1 O ARG C 418 N TYR C 415 SITE 1 AC1 13 GLU A 171 PHE A 174 ALA A 191 LYS A 193 SITE 2 AC1 13 PHE A 243 GLU A 244 LEU A 246 GLU A 294 SITE 3 AC1 13 ASN A 295 LEU A 297 ASP A 327 HOH A 607 SITE 4 AC1 13 HOH A 688 SITE 1 AC2 14 PHE B 174 ALA B 191 LYS B 193 VAL B 227 SITE 2 AC2 14 PHE B 243 GLU B 244 LEU B 246 GLU B 294 SITE 3 AC2 14 ASN B 295 LEU B 297 VAL B 326 ASP B 327 SITE 4 AC2 14 HOH B 685 HOH B 711 SITE 1 AC3 16 GLU C 171 PHE C 174 VAL C 177 ALA C 191 SITE 2 AC3 16 LYS C 193 VAL C 227 PHE C 243 GLU C 244 SITE 3 AC3 16 LEU C 246 GLU C 294 ASN C 295 LEU C 297 SITE 4 AC3 16 VAL C 326 ASP C 327 HOH C 679 HOH C 680 CRYST1 95.633 95.633 222.858 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010457 0.006037 0.000000 0.00000 SCALE2 0.000000 0.012074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004487 0.00000